open access

Vol 13, No 1 (2016)
Review paper
Get Citation

Pridinol — the treatment of neuroleptic-induced extrapyramidal symptoms

Marek Krzystanek
Psychiatria 2016;13(1):47-50.

open access

Vol 13, No 1 (2016)
Prace poglądowe - nadesłane

Abstract

Anticholinergic substances like atropine had been yet used in traditional medicine. Nowadays cholinolitics are broadly used in medicine, especially in neurology with muscle spasticity. Pridinol is the cholinolitic used in psychiatry. The article describes pharmacokinetics, mechanism of pridinol action, its tolerance and toxicology, together with the broad spectrum of its clinical indication with the special consideration of the place the drug has in the treatment of neuroleptic-induced extrapyramidal symptoms. Pridinol is the drug, offering multiple therapeutic gains. It may be very useful for patients with neuroleptic-induced extrapyramidal symptoms

Abstract

Anticholinergic substances like atropine had been yet used in traditional medicine. Nowadays cholinolitics are broadly used in medicine, especially in neurology with muscle spasticity. Pridinol is the cholinolitic used in psychiatry. The article describes pharmacokinetics, mechanism of pridinol action, its tolerance and toxicology, together with the broad spectrum of its clinical indication with the special consideration of the place the drug has in the treatment of neuroleptic-induced extrapyramidal symptoms. Pridinol is the drug, offering multiple therapeutic gains. It may be very useful for patients with neuroleptic-induced extrapyramidal symptoms

Get Citation

Keywords

pridinol, cholinolitic drugs, extrapyramidal symptoms

About this article
Title

Pridinol — the treatment of neuroleptic-induced extrapyramidal symptoms

Journal

Psychiatria (Psychiatry)

Issue

Vol 13, No 1 (2016)

Article type

Review paper

Pages

47-50

Bibliographic record

Psychiatria 2016;13(1):47-50.

Keywords

pridinol
cholinolitic drugs
extrapyramidal symptoms

Authors

Marek Krzystanek

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl